Position:
Director of Business Development at Porton Pharma Solutions Ltd.
Location:
Boston, Massachusetts, United States
Found email addresses for Nathan:
Found phone for Nathan:
Jun 2026 - Current
Dec 2025 - Jun 2026
Nov 2025 - Apr 2026
Jun 2022 - Sep 2025
Sep 2021 - Jun 2022
Dec 2018 - Sep 2021
Mar 2016 - Nov 2018
Sep 2015 - Feb 2016
Nathan is proficient in Chinese and English. Their professional focus is AI-powered antibody engineering, Antibody drug conjugates (ADCs), and Antibody Engineering across 3 core areas.
Nathan holds Introduction to Computational Antibody Engineering, Supervised Machine Learning: Regression and Classification, and 8th The University of Hong Kong- Pasteur Virology Course certifications and has registered patents, including "MOLECULES THAT BIND TO SARS-COV-2, ANAPLASTIC LYMPHOMA KINASE ANTIBODIES AND METHODS OF USE THEREFO, and MOLECULES THAT BIND TO FOLLISTATIN POLYPEPTIDES". They have also been awarded Guest speaker at Pittcon (Philadelphia, 2023), Guest speaker at 10th Immuno oncology summit (Boston, 2022), and Guest speaker in Antibody engineering & therapeutics conference (San Diego, 2021)
Ph.D. at The University of Hong Kong
Master of Studies in Law at University of Pittsburgh School of LAW
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.